Journal of Medical Economics · 2010 · 19 citations · 38 references
MedicineOncologyPreventive MedicineCost-effectiveness AnalysisImmunizationVaccinologyCervical CancerCervical Intraepithelial NeoplasiaCost-effectiveness ModelingModel-based Economic EvaluationVaccinationVaccine EffectivenessAge-specific Cancer IncidenceCost-effectiveness Of Cancer ControlCost-effectiveness Of VaccinationHpv Vaccine CoverageImmunization Cost-effectivenessIncremental Cost EstimationMarkov Cohort ModelingProphylactic Vaccination
OBJECTIVES: the study aims to estimate the clinical-impact and cost-effectiveness value of adding human papillomavirus 16/18 vaccination against cervical cancer among women currently undergoing organised screening in Finland. METHODS: A Markov cohort model evaluating high-risk HPV infections and cervical cancer (CC) cases combined with screening has been customised to the Finnish setting. The model outcome for a cohort of 30,000 girls aged 10 years was calibrated to age-specific annual number of Pap smears, CC incidence and mortality. RESULTS: The observed age-specific incidence and mortality rates of CC closely match the data replicated by the model. The model predicts that with a 90% vaccine coverage rate, CC cases and mortality would be reduced by 70%. In the base-case analysis with a discount rate of 3% the incremental cost per quality-adjusted life-years (QALY) gained, from a healthcare perspective, was €17,294. Without discounting this value is €2,591/QALY gained. CONCLUSIONS: The analysis suggests that implementing prophylactic CC vaccination within the current screening system would substantially reduce CC cases and deaths, as well as the overall disease burden expressed in pre-cancer lesions averted. Vaccination could be a cost-effective intervention in Finland despite the fact that the number of CC cases and deaths are currently relatively low. Conservative estimates of the cost effectiveness of the vaccination were provided since it was not possible to assess herd protection induced by vaccination using this Markov model.
38
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text
Natural History of Cervicovaginal Papillomavirus Infection in Young Women
Robert Bierman, Leah Beardsley, Chee‐Jen Chang et al. · New England Journal of Medicine · 1998 · 2.3K citations · Full text
NATURAL HISTORY OF CERVICOVAGINAL PAPILLOMAVIRUS INFECTION IN YOUNG WOMEN
Guido Ruggero Loria, R Obert B Ierman, L Eah B Eardsley et al. · 1998 · 1.9K citations